BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: He MY, Yan FF, Cen KL, Shen P. Long survival after immunotherapy plus paclitaxel in advanced intrahepatic cholangiocarcinoma: A case report and review of literature. World J Clin Cases 2022; 10(32): 11889-11897 [PMID: 36405269 DOI: 10.12998/wjcc.v10.i32.11889]
URL: https://www.wjgnet.com/2307-8960/full/v10/i32/11889.htm
Number Citing Articles
1
Pedro Luiz Serrano Uson Junior, Tanios Bekaii-Saab. Moving Beyond Single-Agent Checkpoint Inhibition in Biliary Tract Cancers: What is the Next Frontier?Immunotherapy 2023; 15(7): 531 doi: 10.2217/imt-2022-0201
2
Fei Chen, Jian Sheng, Xiaoping Li, Zhaofeng Gao, Siqi Zhao, Lingyu Hu, Minjie Chen, Jianguo Fei, Zhengwei Song. Unveiling the promise of PD1/PD-L1: A new dawn in immunotherapy for cholangiocarcinomaBiomedicine & Pharmacotherapy 2024; 175: 116659 doi: 10.1016/j.biopha.2024.116659
3
Mateusz Gregorczyk, Eileen E. Parkes. Targeting mitotic regulators in cancer as a strategy to enhance immune recognitionDNA Repair 2023; 132: 103583 doi: 10.1016/j.dnarep.2023.103583